Dry powder survives for years because its molecules cannot move. Everything on this page is about keeping it that way.
A vial of peptide can be ruined before it is ever used, by nothing more than where it was kept. The compound looks the same. The powder is still white. Nothing about the vial announces that half of what you paid for has already broken down.
The rules for avoiding that are short. The reasons behind them are more useful. Learn why each rule exists, and you can work out what to do in cases nobody wrote a rule for.
The white cake in the vial was made by freeze-drying. The peptide is frozen, then held under vacuum while the ice turns straight to vapour without ever melting.
Take the water away and the molecules stop moving. They are held in what chemists call a glassy state — rigid, like hard candy, everything locked where it stands. Molecules that cannot move cannot react. A peptide that cannot react does not break down.
That is the whole basis of dry storage. It is why a well-kept powder lasts for years, while the same material in solution lasts weeks.
This is the most important one, and the mechanism is worth following carefully.
The glassy state has a temperature above which it stops being glassy and turns soft. It is called the glass transition temperature, and above it the molecules can move again.
Moisture lowers that temperature. Dramatically.
Nearly dry glass transition around 80 °C 3% moisture drops to roughly 50 °C 8% moisture drops to roughly 25 °C
Read the last line again. At 8% moisture the transition temperature has fallen to about room temperature. A vial sitting on a desk is now above its own transition point. The matrix has softened. The molecules can move. Degradation is running.
This is why you never open a cold vial.
Take a vial from the fridge and pop the cap. The cold surfaces inside pull water out of the air, the way a cold glass sweats on a warm day. That water lands on the powder. You have added moisture, lowered the transition temperature, and started the clock.
Give a cold vial 15 to 30 minutes on the bench, still sealed, before the cap comes off. Once it has reached room temperature there is no difference left to drive condensation. Do not hurry it along with heat.
Every chemical reaction runs faster when it is warmer, and the relationship is steeper than most people expect.
As a rule of thumb, a 10 °C rise roughly doubles the rate of degradation. Ten degrees warmer is twice as fast. Twenty degrees is four times. Thirty is eight.
That is what refrigeration actually buys. Not a vague sense of care, but a large, specific drop in the speed of every reaction that damages the molecule. It is also why an afternoon on the counter costs more than it feels like it should.
Ultraviolet light drives photooxidation, and one amino acid is far more vulnerable than the rest.
Tryptophan breaks down first. What it turns into is itself light-sensitive. So the molecule becomes more vulnerable to light than it was before. Damage speeds up damage.
Tyrosine, methionine and cysteine are also susceptible.
Keep vials in the dark — the original box is fine. A windowsill is the worst place in the room.
Oxygen attacks the same residues: methionine, cysteine, histidine, tryptophan and tyrosine.
A well-made vial arrives sealed under vacuum, or under an unreactive gas such as nitrogen. There is nothing inside to react with. That protection lasts until the first puncture. Every entry through the stopper lets in a little air, and it stays there.
Which is one reason a half-used vial sitting for months is in worse condition than the calendar suggests.
This is the part that causes the most confusion. Getting it straight settles most of the arguments you will see online.
Adding water starts two separate timers that measure completely different things.
Clock one: microbial safety. Once a stopper has been punctured, organisms can get in. Bacteriostatic water contains 0.9% benzyl alcohol, which suppresses bacterial growth. Note the word — bacteriostatic means it stops bacteria multiplying. It does not kill them.
USP <797> is the pharmaceutical standard for sterile compounding. It gives multi-dose containers with a preservative a limit of 28 days after first entry. That is where the widely quoted figure comes from.
Clock two: chemical stability. This tracks the molecule itself coming apart through hydrolysis, oxidation and aggregation. It has nothing to do with bacteria, and it runs at a completely different speed for every compound.
Here is the point that matters:
The 28-day figure is an infection-risk limit. It is not a statement about whether the peptide still works.
A solution can be perfectly safe from a microbial standpoint and substantially degraded. It can also be chemically intact and contaminated. "How long is this good for?" is really two questions, and only the first one has a standard answer.
It does two things. It suppresses bacterial growth by disrupting bacterial cell membranes, and it has a mild numbing effect.
It does not prevent chemical degradation. It does nothing about hydrolysis, deamidation, oxidation or aggregation. The preservative protects the solution from organisms; it does not protect the molecule from chemistry.
There is a further wrinkle worth knowing. Benzyl alcohol has been shown to destabilise some proteins, encouraging partial unfolding that leads to aggregation. The effect depends on concentration and on the specific molecule.
So bacteriostatic water is not automatically the better choice. It is the right choice for a container that will be entered repeatedly over days or weeks. For single-day use, plain sterile water or sterile saline avoids the question entirely.
Some compounds do not tolerate it at all. Oxytocin, desmopressin and vasopressin are the clearest documented cases. Sterile water or saline is used for those instead. The IGF-1 peptides are a separate case again. They are unstable near neutral pH, so they are supplied for reconstitution in dilute acetic acid rather than water. In every case the material's own documentation decides, not a general preference.
Dry powder in a freezer is fine. A solution in a freezer is not. The reasons are worth spelling out, because "do not freeze it" sounds arbitrary until you know them.
Freezing a solution is not lyophilisation. It is just making ice, and ice damages peptides four ways at once:
If something is frozen by accident, thaw it at room temperature, use it soon, and do not refreeze. Some loss should be assumed.
A reconstituted solution should be clear, with no particles and no haze.
Any of those is a reason to discard the vial.
But the limit matters. A clear solution is not evidence of potency. Chemical damage happens at a scale you cannot see. A peptide can break into inactive fragments while the liquid stays perfectly clear. Inspection catches gross failure. It cannot confirm that anything still works.
This deserves stating plainly, because it applies to every storage figure you will encounter, including the ones above.
Research compounds do not come with the stability programmes behind approved medicines. Nobody has run multi-year studies on most of them. The storage numbers circulating online are usually one of three things. Extrapolation from general peptide chemistry. Limited data from a manufacturer. Or the USP <797> microbial limit, repeated as though it described chemical stability.
What is genuinely well established:
What varies by compound, and is often unknown:
What no guide can tell you:
Where sources disagree, the shorter figure is the safer assumption. Where there is no figure at all, treat the material conservatively rather than optimistically. And anything showing visible change should be discarded regardless of what the calendar says.
This article explains published research and the rules around it. It carries no dose, no protocol, and no claim that any compound treats, cures or prevents a condition in anyone. Where the evidence is thin we say so. See our editorial standards.
KLOW is GLOW plus 10 mg of KPV — that part is simple. The more useful fact is that both are, by mass, mostly copper peptide, and that is the ingredient whose injected form has no human trials.
An open study found sleep normalised in six of seven patients. The controlled study by the same investigator found weak effects and said so. The difference between them is a placebo arm.
It does not raise dopamine — it magnifies what other things do to it. That one property explains why caffeine feels stronger on it, and why MAO inhibitors are a hard contraindication.
